Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.63
+0.08 (+5.16%)
Range 1.50 - 1.6378
Open 1.56
Prev Close 1.55
52 Week 1.39 - 3.18
Volume 1410431
Market Cap 837.5M
*Delayed 4/17/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000